Studies of skeletal muscle disuse, either in patients on bed rest or experimentally in animals (immobilization), have demonstrated that decreased protein synthesis is common, with transient parallel increases in protein degradation. Muscle disuse atrophy involves a process of transition from slow to fast myosin fiber types. A shift toward glycolysis, decreased capacity for fat oxidation, and substrate accumulation in atrophied muscles have been reported, as has accommodation of the liver with an increased gluconeogenic capacity. Recent studies have modeled skeletal muscle disuse by using cyclic stretch of differentiated myotubes (C2C12), which mimics the loading pattern of mature skeletal muscle, followed by cessation of stretch. We utilized this model to determine the metabolic changes using non-targeted metabolomics analysis of the Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Introduction
Recovery from injury and illness can cause extended periods of muscle disuse and/or unloading resulting in rapid skeletal muscle atrophy and loss of functional strength [1] [2] [3] . The extent of muscle loss that occurs during illness is an important predictor of hospitalization duration and need for rehabilitation 4 . The resulting decline in functional capacity and strength, decline in basal metabolic rate, and onset of insulin resistance reported to be some of the sequelae in humans 5 . Since the signs of muscle disuse atrophy occurs rapidly, understanding the short term alterations that occur may help us better appreciate their contribution to sarcopenia and elucidate ways in which to counteract the particularly fast and severe consequences that result.
Studies of skeletal muscle disuse either in patients on bed rest or experimentally in animals (immobilization) have demonstrated that decreased protein synthesis is common, with transient parallel increases in protein degradation (as recently reviewed 5 ). Muscle disuse atrophy involves a process of transition from slow to fast myosin fiber types 6 . A shift toward glycolysis, decreased capacity for fat oxidation, and substrate accumulation in atrophied muscles have been reported, as has accommodation of the liver with an increased gluconeogenic capacity 6 . These alterations in glycolysis appear to regulate more than carbohydrate metabolism 7 .
targeted metabolomics approach of both cells and media in vitro. While we identified previously reported effects on glucose utilization, a host of previously undescribed alterations in protein metabolism was found and offers insight into the mechanisms underlying acute skeletal muscle disuse atrophy that may be targeted therapeutically in the future.
Materials and Methods

C2C12 plating and differentiation on FlexCell plates
The C2C12 mouse myoblast cell line (ATCC, CRL-1772) was plated at 30-50% confluence onto six-well BioFlex® culture plates (BF-3001, Flexcell International Corporation, Hillsborough, NC) coated with Collagen type I. Myoblasts were grown to 80% confluence in DMEM (4500 mg/L glucose) with 20% FBS, then differentiated to myotubes by changing media to DMEM with 2% horse serum supplemented with insulin (1 microM final), as previously described [9] [10] [11] . Cells were plated were then allowed to quiesce in DMEM (25 mM glucose) without media for 24 hours before stretch stimulus was applied to quiesce the cells, as previously described in the context of cardiomyocyte-induced hypertrophy by IGF-1 and thyroid hormone in vitro 12,13 .
Biomechanical stretch of differentiated C2C12 cells
Differentiated C2C12 cells were either stretched at 15% biaxial stretch for 6 hours using the Flexcell ® FX-5000™ Compression System (Flexcell International Corporation, Hillsborough, NC), or used as controls (non-stretched) and incubated in parallel to experimental cells without stretch (non-stretched cells). The stretched differentiated C2C12 cells were then unloaded by stopping the stretch and allowing the cells to incubate for another 12 hours. Media was collected at baseline, or after 6 hours of stretch, and 1, 3, 6, and 12 hours after the cessation of stretch. Replicate control samples and cells undergoing cessation of stretch were maintained under static conditions with no applied cyclic strain. In parallel, second experimental group of differentiated C2C12 cells were stimulated with 10% FBS for 6 hours to induce hypertrophy (experimental controls were incubated in parallel without FBS).
Imaging and cell surface area determinations
Cultured myotubes were viewed and imaged using a Zeiss inverted microscope (Axiovert 200, Oberkochen, Germany). Three digital images per culture were captured. The images were analyzed for myotube length, diameter and area using ImageJ imaging software (NIH) as previously described 8 .
Non-targeted metabolomics analysis
Collection of samples (spent media) from all 6 wells was performed, and samples were placed on dry ice/stored at −80°C. Samples were then analyzed by GC/MS, as previously described 14 . The raw, transformed, and sorted data used for each of the three comparisons in the metabolomics analyses can be found in Supplemental Table 1 . Up to 1 missing value per group was imputed using lowest value in the same group, with groups missing 2 or more excluded from the analysis. All data used in this analysis has been archived in the UCSD Metabolomics Workbench (http://www.metabolomicsworkbench.org/), accession #(Pending Assignment).
Metabolomic statistical analyses
Metaboanalyst (v3.0) run on the statistical package R (v2.14.0) used metabolite peaks areas (as representative of concentration) 19, 20 . Data were first normalized to a pooled average sample from their control and scaled using Pareto scaling feature, and then analyzed to calculate fold change using Metaboanalyst fold change feature. Unsupervised principal component analysis (PCA) was performed next, which identified the effect of stretch cessation as the principal source of variance. The metabolites that best differentiated the groups were then individually tested using univariate analysis of individual component by ttest (Metaboanalyst v 3.0), and then the t-test and VIP significant metabolites were matched to metabolomics pathways using the Pathway Analysis and enrichment analysis features in Metaboanalyst 3.0. In addition, a Pairwise One-Way Analysis of Variance (ANOVA) and Fisher LSD post-hoc were conducted among all groups at different time points using Metaboanalyst v3.0 to delineate the changes induced by stretch and cessation. Only metabolites identified and detected in all groups were included in the One-Way ANOVA. If two or more values of each metabolite were missing in a given group, the entire metabolite was removed from the analysis. Data used in this study are available in Supplemental Table  1 . Heat maps were generated using the GENE-E software (http://www.broadinstitute.org/ cancer/software/GENE-E/index.html). All data is shown as mean +/− standard error of the mean (SEM), unless otherwise indicated.
Results
Using differentiated C2C12 myotubes seeded at the same time with equal numbers of cells, we cyclically stretched cells (15% at 60 cycles/min) for 6 hours, then stopped the stretch and collected media at 1, 3, 6, and 12 hours post-stretch. Media from the same cells were collected just before and 6 hours post-stretch (indicated by 0 h) was analyzed using nontargeted metabolomics ( Figure 1A ). Compared to non-stretch controls, C2C12 cells significantly increased in cross-sectional are after 6 hours ( Figure 1B ). Stretch cessation resulted in a significant reduction in myocyte area within 3 hours ( Figure 1B ), which continued to decrease at 6 and 12 hours, respectively. To discover the alterations that occurred metabolically in these myocytes, we analyzed the media in the stretch cells and compared it to non-stretched cells in vitro, investigating each of the five times analyzed (6 hours stretch, and 1, 3, 6, and 12 hours post-stretch cessation).
Using non-targeted metabolomics analysis, we compared the metabolites found in control no-stretch cell media to cells stretched for 6 hours without serum ( Figure 2 ). We identified eighty-two metabolites (of 110 substances peaks recorded)( Figure 2A ). Of the 82 metabolites named, 12 were significantly different from non-stretch controls by t-test ( Figure 2B ). By category, stretch affected arginine/proline metabolism and starch/sucrose metabolism ( Figure 2C ). We identified 84 metabolites in serum-stimulated C2C12 cells (Supplemental Figure 1A) , with 32 of them significantly different from parallel controls (Supplemental Figure 1B) . Like stretch-induced hypertrophy, serum-stimulated C2C12 cells showed significant alterations in protein biosynthesis and alanine metabolic pathway as the most enriched pathways and lowest p-value (Supplemental Figure 1) . Twelve (12) significantly altered metabolites were found in the stretch challenged C2C12 cells compared to thirty-two (32) in the serum-induced after 6 hours illustrate the many differences in these stimuli as well, including citrate cycle, arginine/proline metabolism, and glycine/serine/ threonine metabolic pathways identified (Supplemental Figure 1) . Pathway enrichment analysis of the 6 hours stretch and 6-hour serum significant metabolites illustrate the similarities between the two, including "protein biosynthesis" and "alanine metabolism" having the lowest p values, while citric acid cycle changes were unique to the serumstimulated pathway (Supplemental Figure 2) .
After identifying the metabolic alterations that occurred with stretch, we next determined the metabolic changes at 1, 3, 6, and 12 hours after (Figures 3-6 ). After 1 hour, three metabolites were significantly different between groups (of 83 metabolites identified from 191 substance peaks recorded)( Figure 3A and 3B), involving starch and sucrose metabolism ( Figure 3C ). Similarly, after 3 hours of stretch cessation, nine metabolites were significantly different between groups (from 87 metabolites identified from 197 substances peaks recorded)( Figure 4A and 4B), also involving aminoacyl-tRNA biosynthesis ( Figure 4C ). At 6 hours of stretch cessation, 16 metabolites were significantly different between groups (of 86 metabolites identified from 196 substances peaks recorded)( Figure 5A and 5B), involving valine/leucine/isoleucine biosynthesis, pyruvate metabolism, and aminoacyl-tRNA biosynthesis ( Figure 5C (Figure 7 ). Since glucose uptake occurs in response to stretch, we followed media glucose levels as it was an identified metabolites found throughout. Glucose levels did not significantly change throughout the time course (Supplemental Figure 5 ). Significant increases in lactic acid, citric acid, α-ketoglutaric acid, and malate were identified and significantly increased by 12 hours of stretch cessation and hypertrophy reversal (see inset plots). Both ANOVA and t-tests identified decreases in pyruvate, complementing the analysis performed in Figure 6 , investigating the significant alterations by t-test at the 12-hour stretch cessation compared to the 6-hour hypertrophy time point (0 Hr), indicated in blue and red. In addition to the ANOVA significant findings, fumarate was found to be decreased 3.5 fold (Figure 7 ).
One-way ANOVA performed on all the time points revealed alterations in alanine and proline metabolism ( Figure 8 ). As adjacent pathways to the Kreb's cycle, increases in proline, alanine, glutamine, and asparagine were increased with the cessation of stretch by 3-12 hours (Figure 8, see inset graphs) . In addition to the ANOVA significant metabolites, the 12 hours t-test identified glutamate and glycine reduced (see metabolites in blue, Figure 8 ). Lastly, ANOVA significant metabolites were also identified in purine metabolism (Supplemental Figure 3A) , branched chain amino acid synthesis (Supplemental Figure 3B) , phospholipid metabolism (Supplemental Figure 3C) , and in pathways not clearly delineated, including sugar alcohols identified as pentitols and hexitols (Supplemental Figure 4) .
Discussion
Recent studies have demonstrated that cyclic stretch of differentiated C2C12 myotubes for as little as 1 hour per day (12% at 0.7 Hz) increases myocyte size in as little as two days 8 . To streamline this model, we found that in preliminary studies that stretching cells similarly (15% at 1.0 Hz) could induce myocyte growth in 6 hours, which became the basis for the present study. Cyclic stretch of C2C12 myotubes induces the release IGF-1 and AngII, which act as autocrine/paracrine stimulators of IGF-1 8 and Angiotensin II 15 signaling on the C2C12 cells themselves, inducing an increase in cell size. As myocyte hypertrophy represents the increase in newly synthesized sarcomeres, the significance of the observed IGF-1 induced protein synthesis (evidenced by increased p-Akt and p-GSK3beta, respectively) is clear. Conversely, cessation of stretch reproducibly causes a loss of myocyte mass 8 , involving the proteasome-dependent degradation of sarcomere proteins that involves both the ubiquitin-proteasome system and calpain enzymes 16, 17 . The myocyte-specific ubiquitin ligases MuRF1 and MAFbx mediate muscle atrophy 18 , recognizing and ubiquitinating sarcomere proteins, then targeted for proteasome-dependent degradation 19 . Atrophy in C2C12 myotubes can be inhibited by blocking the proteasome 20 or by blocking ubiquitination to prevent atrophy in C2C12 myotubes 16 . Recent studies have identified that activating calpain enzymes serve to induce the ubiquitin-proteasome pathway, thereby acting in concerted to degrade sarcomere proteins during atrophy 21 .
The induction of anaplerosis in atrophy is an important compensatory mechanism by which amino acids feed the TCA cycle to generate energy. The link between atrophy and anaplerosis is logical, given the tremendous sarcomere protein degradation that occurs, freeing peptides and amino acids used for energy. In addition to the structural changes that occur with muscle unloading and atrophy, recent studies have identified an intricate link between skeletal muscle mass regulation and energy metabolism 22 . Conceptually, this link lies in the well-established increase in net protein degradation that produces an increase in amino acids 5, 7, 23 . During the development and progression of colorectal cancer, tumorbearing animals experienced decreases in pyruvate kinase (PKM1) and pyruvate kinase activity but were unexpectedly able to maintain energy 7 . These studies revealed that an increase in autophagy supported the loss of muscle mass and increased amino acid production, including increased glutamine 7 . Through a well-known process of anaplerosis that occurs in skeletal muscle, glutaminase can change glutamine to glutamate, whereby glutamate dehydrogenase can create the α-ketoglutaric acid intermediate to feed the TCA cycle 24, 25 . During the progression of skeletal muscle atrophy due to cancer, increases in glutamine were thought to be the main mechanism by which ATP levels were maintained in the presence of decreased pyruvate kinase activity 7 . In the present study, we expand this evidence to demonstrate increases in alanine/proline metabolism (significantly elevated proline, alanine, glutamine, and asparagine, (Figure 8 ) and increased α-ketoglutaric acid, the proposed intermediate (Figure 7) being fed by the alanine/proline metabolic anaplerotic mechanism. Lastly, the anaplerotic pathway shunting pyruvate to malate has been described as a potential anaplerotic mechanism in skeletal muscle through the malic enzyme 26 . While it has not clearly been described to our knowledge in unloading, it may be at work in the present model to describe the elevated malate seen after unloading (Figure 7 ).
In addition to the anaplerotic mechanism feeding α-ketoglutaric acid seen with C2C12 unloading, we identified several unique pathways not clearly delineated in previous studies of muscle unloading. The CDP-ethanolamine pathway has been described to regulate skeletal muscle diacylglycerol content and mitochondrial biogenesis 27 . The drug clenbuterol is an ethanolamine that has been used to treat skeletal muscle atrophy, including dexamethasone-induced muscle atrophy 28 , denervated skeletal muscle 29 , and in treating humans with spinal and bulbar muscular atrophy for a 12 month trial 30 . These studies indicate that the ethanolamine clenbuterol protects skeletal muscle loss by antagonizing Akt/ mTOR and by increasing polyamines (putrescine, spermidine, and spermine), which are repressed in muscle atrophy [31] [32] [33] . The presence of elevated ethanolamine may represent novel endogenous pathways involved in the recovery of atrophy (Supplemental Figure 3C) . Significantly increased concentration of the keto-acids derived from branched chain amino acids (i.e. 2-ketoleucine and 2-keovaline) were identified after unloading (Supplemental Figure 3B ) and have been described as intermediates in the Ehrlich amino acid degradation pathway. These keto-acids derived from branched chain amino acids feed into a metabolic pathway supplying acetyl-CoA and 2-hydroxybutyrate (also significantly increased, Figure  7 ). Since the keto-amino acids are further reacted in this pathway to make higher alcohols, it is possible that the generic sugar alcohols may be related to this process (Supplemental Figure 4A ). While the elevation of amino acids during skeletal muscle atrophy is well known 34 , the keto-acids derived from branched chain amino acids seen here have not previously been described specifically. Lastly, elevated guanine was seen at 12 hours unloading, which previously was undetectable at multiple time points (Supplemental Figure  3A) . While guanine is an intermediate in purine metabolism, its role in unloading remodeling has not been described to our knowledge in the literature previously.
Metabolomic analysis of cell culture can involve extracellular (footprint) and intracellular (fingerprint) metabolic profiles. One advantage of metabolic footprinting is the ability to assay serially, as in the present study, to allow identification of changes over time in the same cell culture system. Footprinting of B-lymphocytes into Ig secreting plasma cells using supernatants identified the consumption of glucose, glutamine, and other essential amino acids 35 . 5′-methylthioadenosine (5′MTA) was produced and released during the activation phase, while the second phase of differentiation corresponded to deoxycytidine release 35 . Changes in extracellular metabolites correlated with the known biochemical pathway changes reported previously 35 . The secretome footprinting of cancer cells has similarly shown parallels between the metabolites secreted and the underlying biology of the cells releasing these metaoblites 36 . Specifically, identification of isoleucine, α-aminoadipic acid (AADA), and γ-amino-N-butyric acid (GABA) in media were accurate biomarkers of cMyc, KLF4, and Oct1 variable expression, with modulation of these markers indicative of changes in the underlying biology of the tumor 36 . The reason for the parallel metabolic mirroring of the footprint with the intracellular (fingerprint) in these studies is not addressed directly in these studies.
One potential mechanism that may explain the parallel metabolomics profiles seen in extracellular media and cells alike may be exosome-like vesicles (ELV) 37 . Small molecule profiling from ELVs isolated from cell culture media has recently demonstrated to be much more dynamic. The rich metabolome that was found included glycerophospholipids/ sphingolipids, peptides, cyclic alcohols, fatty acid esters/amides, alcohols, sugars, steroids, amino acids/conjugates, nucleotides, and organic acids in cell culture media from exosomelike vesicles found in the media 37 . While we did not isolate ELVs from media in the present study, this finding demonstrates that the diversity of metabolites we did identify have been reported in media ELVs as a source. The transport and movement of these diverse metabolites are not well described but are different enough that multiple mechanisms, including those outside of ELVs not previously described, may similarly be involved.
A limitation of this study is the limited fatty acids available to the differentiated C2C12 cells during the stretch phase and subsequent hypertrophy reversal. C2C12 cells have the ability to take up and oxidize fatty acids for energy production and have the ability to store fats as triglycerides as well 38 . Adequate supplementation of fatty acids complexed to albumin was available in the serum used to proliferate and differentiate these cells. DMEM with 10% fetal bovine serum was used to induce proliferation of C2C12 myoblasts; the media was then replaced with DMEM with 2% horse serum to induce differentiation. However, the stretch studies were then performed in the absence of serum as serum is a potent inducer of hypertrophic growth (containing IGF-1, Angiotensin II, and thyroid hormone, among other pro-hypertrophic constituents 8, 15 ; see serum-induced hypertrophic controls, Supplemental Figure 1 ). While fatty acids were not directly added to the media via serum for these reasons, fatty acids were identified in the media by our present analysis. Specifically, palmitic acid, alpha-Monopalmitin, and/or Beta-Monopalmitin were found at each time found (Supplemental Table 1 ). Recent studies have demonstrated that the essential fatty acids linoleic acid (LA) and alpha-linolenic acid (ALA) themselves can improve glucose uptake in C2C12 cells made insulin resistant using palmitic acid 39 , making the balance between fatty acids and glucose critically important when modeling myocytes in vitro.
Conclusions
Cessation of biaxial stretch in C2C12 myotubes in culture resulted in a reduction in crosssectional area over 12 hours, paralleling some metabolic changes using non-targeted metabolomics analysis of the media. Using a One-Way ANOVA analysis comparing the cessation time point, increases in amino acids were identified, resulting from the protein degradation (largely sarcomere) that occurs with muscle atrophy. Increases in alanine/proline metabolism (significantly elevated proline, alanine, glutamine, and asparagine) and increased α-ketoglutaric acid, the proposed intermediate being fed by the alanine/proline metabolic anaplerotic mechanism were identified. Additionally, several unique pathways not clearly delineated in previous studies of muscle unloading were seen, including: 1) elevated keto-acids derived from branched chain amino acids (i.e. 2-ketoleucine and 2-keovaline), which feed into a metabolic pathway supplying acetyl-CoA and 2-hydroxybutyrate (also significantly increased); and 2) elevated guanine, an intermediate of purine metabolism, was seen at 12 hours unloading. Given the interest in targeting different aspects of the ubiquitinproteasome system to inhibit protein degradation 18, 40, 41 , this C2C12 system may allow the identification of direct and indirect alterations in metabolism due to anaplerosis or through other yet to be identified mechanisms using a non-targeted metabolomics approach.
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